CI Investments Inc’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.32M Sell
225,169
-28,597
-11% -$761K 0.03% 268
2025
Q4
$6.32M Sell
253,766
-18,431
-7% -$465K 0.03% 270
2025
Q3
$6.94M Sell
272,197
-30,603
-10% -$755K 0.03% 256
2025
Q2
$7.34M Buy
302,800
+17,630
+6% +$411K 0.03% 260
2025
Q1
$7.23M Sell
285,170
-247,130
-46% -$6.47M 0.03% 259
2024
Q4
$14.1M Buy
532,300
+29,754
+6% +$807K 0.05% 203
2024
Q3
$14.5M Buy
502,546
+25,827
+5% +$753K 0.06% 200
2024
Q2
$13.3M Buy
476,719
+167,221
+54% +$4.6M 0.05% 198
2024
Q1
$8.59M Buy
309,498
+43,878
+17% +$1.22M 0.03% 240
2023
Q4
$7.65M Sell
265,620
-181,456
-41% -$5.49M 0.04% 244
2023
Q3
$14.8M Sell
447,076
-6,753
-1% -$239K 0.08% 185
2023
Q2
$16.6M Sell
453,829
-245,658
-35% -$9.56M 0.08% 183
2023
Q1
$28.5M Sell
699,487
-132,288
-16% -$5.71M 0.14% 143
2022
Q4
$42.6M Buy
831,775
+1,136
+0.1% +$54.5K 0.22% 111
2022
Q3
$36.3M Buy
830,639
+8,498
+1% +$413K 0.19% 119
2022
Q2
$43.1M Sell
822,141
-378,246
-32% -$19.3M 0.2% 120
2022
Q1
$62.1M Buy
1,200,387
+148,643
+14% +$7.71M 0.23% 113
2021
Q4
$62.1M Buy
1,051,744
+243,856
+30% +$12.1M 0.21% 125
2021
Q3
$34.7M Sell
807,888
-89,112
-10% -$3.95M 0.13% 161
2021
Q2
$35.1M Buy
897,000
+14,799
+2% +$575K 0.13% 160
2021
Q1
$32M Sell
882,201
-99,541
-10% -$3.53M 0.13% 161
2020
Q4
$36.1M Buy
981,742
+152,491
+18% +$5.59M 0.16% 147
2020
Q3
$28.9M Sell
829,251
-30,879
-4% -$1.08M 0.14% 137
2020
Q2
$26.7M Buy
860,130
+150,635
+21% +$5.12M 0.14% 130
2020
Q1
$22M Sell
709,495
-284,305
-29% -$9.69M 0.13% 131
2019
Q4
$36.9M Sell
993,800
-1,664,496
-63% -$59.3M 0.19% 132
2019
Q3
$90.6M Sell
2,658,296
-381,756
-13% -$13.9M 0.47% 67
2019
Q2
$126M Buy
3,040,052
+1,813,512
+148% +$72M 0.7% 47
2019
Q1
$49.4M Sell
1,226,540
-2,081,030
-63% -$83.3M 0.28% 105
2018
Q4
$137M Sell
3,307,570
-882,225
-21% -$36.6M 0.88% 34
2018
Q3
$175M Sell
4,189,795
-1,629,638
-28% -$62.7M 1.31% 13
2018
Q2
$200M Buy
5,819,433
+1,602,384
+38% +$54.8M 1.57% 12
2018
Q1
$142M Sell
4,217,049
-1,617,845
-28% -$55.6M 1.63% 14
2017
Q4
$201M Buy
5,834,894
+1,657,315
+40% +$56.5M 2.06% 11
2017
Q3
$141M Buy
4,177,579
+634,358
+18% +$20.4M 1.38% 24
2017
Q2
$113M Buy
3,543,221
+1,068,407
+43% +$33.7M 1.22% 24
2017
Q1
$80.3M Buy
2,474,814
+345,391
+16% +$10.9M 0.91% 35
2016
Q4
$65.6M Buy
2,129,423
+618,830
+41% +$18.9M 0.72% 47
2016
Q3
$48.5M Sell
1,510,593
-922,566
-38% -$30.8M 0.53% 58
2016
Q2
$81.3M Sell
2,433,159
-34,887
-1% -$1.11M 0.92% 35
2016
Q1
$69.4M Buy
2,468,046
+1,405,087
+132% +$40.1M 0.89% 38
2015
Q4
$32.6M Buy
1,062,959
+5,692
+0.5% +$179K 0.42% 61
2015
Q3
$31.5M Sell
1,057,267
-1,352,809
-56% -$43.4M 0.41% 68
2015
Q2
$76.7M Sell
2,410,076
-727,682
-23% -$23.7M 0.85% 35
2015
Q1
$104M Buy
3,137,758
+2,499,245
+391% +$79.5M 1.09% 25
2014
Q4
$18.9M Buy
638,513
+14,545
+2% +$417K 0.21% 93
2014
Q3
$17.5M Buy
623,968
+31,409
+5% +$882K 0.18% 97
2014
Q2
$16.7M Buy
+592,559
New +$16.9M 0.16% 100

Other funds holding PFE

CI Investments Inc's PFE Position: Q1 2026 in Review

CI Investments Inc reduced its Pfizer (PFE) stake by 11% in Q1 2026, selling an estimated $761K and leaving 225,169 shares worth $6.32M. The position accounts for 0.03% of the portfolio, ranked #268.

CI Investments Inc first reported a position in PFE in Q2 2014 and has held it in 48 quarters since. The position peaked at $201M in Q4 2017. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • CI Investments Inc held 225,169 shares of Pfizer worth $6.32M as of Q1 2026.
  • CI Investments Inc sold 28,597 Pfizer shares in Q1 2026, an estimated $761K.
  • Pfizer made up 0.03% of CI Investments Inc's portfolio in Q1 2026, its #268 holding.
  • CI Investments Inc first reported a position in Pfizer in Q2 2014 and has held it in 48 quarters since.
  • CI Investments Inc's Pfizer position peaked at $201M in Q4 2017.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on CI Investments Inc's 13F filing for Q1 2026, filed 13 May 2026.